Dravet syndrome: Seizure control and gait in adults with different SCN1A mutations

Epilepsia

Volumn 53, Issue 8, 2012, Pages 1421-1428

  Rilstone, Jennifer J ^a,b   Coelho, Fernando M ^b,c   Minassian, Berge A ^a,b   Andrade, Danielle M ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Ataxia; Crouch gait; Dravet syndrome; Genotype; Pore forming region; SCN1A; Seizures

Indexed keywords

SODIUM CHANNEL NAV1.1;

ADULT; CLINICAL ARTICLE; EPILEPTIC STATE; FEMALE; GAIT; GAIT DISORDER; GENE FREQUENCY; GENE MUTATION; HUMAN; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY;

ADOLESCENT; ADULT; AGE FACTORS; ANTICONVULSANTS; CODON, NONSENSE; EPILEPSIES, MYOCLONIC; FEMALE; GAIT; GAIT DISORDERS, NEUROLOGIC; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; PHENOTYPE; SEIZURES; SODIUM CHANNELS; YOUNG ADULT;

EID: 84864985131     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03583.x     Document Type: Review

References (21)

1. Akiyama M, Kobayashi K, Yoshinaga H, Ohtsuka Y,. (2010) A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 51: 1043-1052.
2. Andrade DM, Hamani C, Lozano AM, Wennberg RA,. (2010) Dravet syndrome and deep brain stimulation: seizure control after 10 years of treatment. Epilepsia 51: 1314-1316.
3. Catterall WA,. (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26: 13-25.
4. Chen Z, Alcayaga C, Suarez-Isla BA, O'Rourke B, Tomaselli G, Marban E,. (2002) A "minimal" sodium channel construct consisting of ligated S5-P-S6 segments forms a toxin-activatable ionophore. J Biol Chem 277: 24653-24658.
5. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P,. (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68: 1327-1332.
6. Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I, Bouteiller D, Carpentier W, Keren B, Abert B, Gautier A, Baulac S, Arzimanoglou A, Cazeneuve C, Nabbout R, LeGuern E,. (2009) Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 46: 183-191.
7. Dravet C,. (1978) Les epilepsies graves de l'enfant. La vie Medicale 8: 543-548.
8. Dravet C, Bureau M, Oguni H,. (2002) Severe myoclonic epilepsy in infancy. In, Roger JBM, Dravet C, Genton P, Tassinri CA, Wolf P, (Ed) Epileptic syndromes in infancy, childhood and adolescence. Libbey, London, pp. 81-104.
9. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O,. (2005) Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 95: 71-102.
10. Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, An-Gourfinkel I, Brice A, LeGuern E, Moulard B, Chaigne D, Buresi C, Malafosse A,. (2000) Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS + 2. Nat Genet 24: 343-345.
11. Gennaro E, Santorelli FM, Bertini E, Buti D, Gaggero R, Gobbi G, Lini M, Granata T, Freri E, Parmeggiani A, Striano P, Veggiotti P, Cardinali S, Bricarelli FD, Minetti C, Zara F,. (2006) Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. Biochem Biophys Res Commun 341: 489-493.
12. Genton P, Velizarova R, Dravet C,. (2011) Dravet syndrome: the long-term outcome. Epilepsia 52 (Suppl. 2): 44-49.
13. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O,. (1998) Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39: 508-512.
14. Jansen FE, Sadleir LG, Harkin LA, Vadlamudi L, McMahon JM, Mulley JC, Scheffer IE, Berkovic SF,. (2006) Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 67: 2224-2226.
15. Kalume F, Yu FH, Westenbroek RE, Scheuer T, Catterall WA,. (2007) Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci 27: 11065-11074.
16. Kanai K, Hirose S, Oguni H, Fukuma G, Shirasaka Y, Miyajima T, Wada K, Iwasa H, Yasumoto S, Matsuo M, Ito M, Mitsudome A, Kaneko S,. (2004) Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology 63: 329-334.
17. Nicita F, Spalice A, Papetti L, Ursitti F, Parisi P, Gennaro E, Zara F, Iannetti P,. (2010) Genotype-phenotype correlations in a group of 15 SCN1A-mutated Italian patients with GEFS+ spectrum (seizures plus, classical and borderline severe myoclonic epilepsy of infancy). J Child Neurol 25: 1369-1376.
18. Ogino T, Ohtsuka Y, Amano R, Yamatogi Y, Ohtahara S,. (1988) An investigation on the borderland of severe myoclonic epilepsy in infancy. Jpn J Psychiatry Neurol 42: 554-555.
19. Rodda JS, McMahon J, Berkovic S, Graham K,. (2008) Gait and function in Dravet syndrome. Gait Posture 28S: S14.
20. Striano P, Striano S, Minetti C, Zara F,. (2008) Refractory, life-threatening status epilepticus in a 3-year-old girl. Lancet Neurol 7: 278-284.
21. Wallace RH, Hodgson BL, Grinton BE, Gardiner RM, Robinson R, Rodriguez-Casero V, Sadleir L, Morgan J, Harkin LA, Dibbens LM, Yamamoto T, Andermann E, Mulley JC, Berkovic SF,. (2001) Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 68: 859-865.